Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Pilot Study of the Effect of Cabergoline on Body Weight and Glucose Tolerance in Healthy Obese Adults

NCT01395602 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT01395602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01395602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Pilot Study of the Effect of Cabergoline on Body Weight and Glucose Tolerance in Healthy Obese Adults
Lead sponsor
Columbia University
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2002
Completion date
July 31, 2011
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

body weight, impaired glucose tolerance in obese